Publications by authors named "O Dalesio"

Claim this Profile
R
Randomized Phase III Study to Assess Efficacy and Safety of Adjuvant CAPOX with or without Bevacizumab in Patients after Resection of Colorectal Liver Metastases: HEPATICA study.
Nikol Snoeren, Richard van Hillegersberg, Sander B Schouten, Andre M Bergman, Erikv van Werkhoven, Otilia Dalesio

Neoplasia· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Professor Maurice Staquet, MD, MS (1930 - 2013).
Nicole Duez, Dominique Eeckhoudt, Anne Kirkpatrick, Gabriel Solbu, Stefan Suciu, Otilia Dalesio

Stat Med· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study.
J G Aerts, H Codrington, N A G Lankheet, S Burgers, B Biesma, O Dalesio

Ann Oncol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro).
H J Meulenbeld, E D van Werkhoven, J L L M Coenen, G J Creemers, O J L Loosveld, O Dalesio

Eur J Cancer· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, placebo-controlled phase III study of docetaxel plus carboplatin with celecoxib and cyclooxygenase-2 expression as a biomarker for patients with advanced non-small-cell lung cancer: the NVALT-4 study.
Harry J M Groen, Hannie Sietsma, Andrew Vincent, Monique M H Hochstenbag, John W G van Putten, Otilia Dalesio

J Clin Oncol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis